Products & ReviewClinical Diagnostics

Lumipulse® G β-Amyloid 1-40 Plasma (RUO)

Fujirebio81298Available: ,Western Europe,Asia,Eastern Europe,Middle East,

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma.

0.0/5.0

|0 Reviews|Be the first to review this product

Request Pricing

Receive your quote directly from the manufacturer.

Ease of Use

After Sales Service

Value for Money

Be the first to leave a review

Description

Description
News & Articles

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma.

Editorial ArticleClinical Diagnostics

Fujirebio integration of ADx NeuroSciences expands neurodiagnostic biomarker capabilities

Fujirebio Europe N.V. explains how the full integration of ADx NeuroSciences strengthens its end-to-end model for neurological biomarker development, from early discovery to routine clinical application

13 Jul 2026

Product Overview

Lumipulse® G β-Amyloid 1-40 Plasma (RUO) - Fujirebio - Clinical Diagnostics

Lumipulse® G β-Amyloid 1-40 Plasma (RUO)

0.0/5.0

Request Pricing

Links

Fujirebio Manufacturer Website

Featured products

Request Quote for All Products

Lumipulse® G pTau 217 Plasma (CE marked (IVDR))
Fujirebio
Lumipulse G pTau 217 Plasma is a test for in vitro diagnostic use with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA).
(0)
Lumipulse® G NfL Blood (CE marked (IVDR))
Fujirebio
Lumipulse G NfL Blood is a quantitative test for in vitro diagnostic use with the automated LUMIPULSE G System for the measurement of neurofilament light chain (NfL) in human blood (serum/plasma) in patients with neurological diseases.
(0)
INNO-LiPA® HPV Genotyping Extra II
Fujirebio
Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
(0)
PreCursor-M+
Fujirebio
Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.
(0)
HPV-Risk assay
Fujirebio
Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.
(0)
AmpFire® HPV High Risk Genotyping
Fujirebio
Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.
(0)
AmpFire® HPV Screening 16/18/HR
Fujirebio
Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.
(0)
PreCursor-M AnoGYN (RUO)
Fujirebio
PreCursor-M AnoGYN is a methylation-specific molecular assay to detect promoter hypermethylation of the human genes ASCL1 and ZNF582 in bisulfite-converted DNA prepared from human samples, for instance formalin-fixed paraffin embedded anal biopsies or anal swab specimens.
(0)
Lumipulse® G NfL Blood (RUO)
Fujirebio
Immunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of neurofilament light (NfL) in human plasma and serum.
(0)
Lumipulse® G pTau 217 Plasma (RUO)
Fujirebio
Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma.
(0)
Lumipulse® G pTau 181 Plasma (RUO)
Fujirebio
Immunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human plasma.
(0)

Buy Lumipulse® G β-Amyloid 1-40 Plasma (RUO) Read Reviews